{
  "ptid_time": "094_S_4162_2011-08-16",
  "img_path": "/data/qiuhui/data/adni/images/094_S_4162/2011-08-16/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 41,883 mm³, 49.2% above the reference mean. With a Z-score of 1.13 (87.0th percentile), this represents mild enlargement; hippocampal volume measures 6,488 mm³, 8.8% below the reference mean. With a Z-score of -0.81 (21.0th percentile), this represents normal volume ; whole brain volume measures 1,045,130 mm³, 7.2% above the reference mean. With a Z-score of 0.91 (81.9th percentile), this represents normal volume ; entorhinal cortex volume measures 3,855 mm³, 5.0% above the reference mean. With a Z-score of 0.30 (62.0th percentile), this represents normal volume ; fusiform gyrus volume measures 18,274 mm³, 7.4% above the reference mean. With a Z-score of 0.67 (75.0th percentile), this represents normal volume ; middle temporal gyrus volume measures 20,620 mm³, 7.6% above the reference mean. With a Z-score of 0.66 (74.4th percentile), this represents normal volume . ",
  "text_data": "Age is 71.3 years. Gender is Female. Education: 16 years. Handedness: Right. Race: White. Medical history: Psychiatric; Alcohol Abuse; Smoking; Malignancy; Major Surgical Procedures. MMSE: 26.0. MoCA: 23.0. Logical Memory: 0.0. Laboratory findings: Monocytes: 0.81 (profound elevated); Basophils: 0.15 (profound elevated); Platelets: 385.00 (significant elevated); Basophils: 1.40 (significant elevated); WBC: 10.72 (profound elevated); Neutrophils: 6.27 (significant elevated); Lymphocytes: 3.27 (profound elevated); Triglycerides (GPO): 245.00 (significant elevated). APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.45 SUVR (significant elevated); Amyloid beta: 778.80 pg/mL (normal ); Total tau: 340.70 pg/mL (mild elevated); Phosphorylated tau: 35.37 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows mild ventricular enlargement and normal hippocampal volume, but cognitive testing (MMSE 26, MoCA 23) suggests mild impairment. Biomarkers (elevated T-tau, P-tau, and AV45) indicate amyloid pathology, while Aβ is normal, which may suggest tauopathy or mixed pathology.  \n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (Cognitive scores are borderline, and biomarker profile is mixed but suggestive of neurodegeneration.)",
  "timestamp": "2025-07-26T10:28:51.108624"
}